Alterity Therapeutics (ATHE) Payables (2017 - 2018)

Alterity Therapeutics (ATHE) has 2 years of Payables data on record, last reported at $1.0 million in Q2 2018.

  • For Q2 2018, Payables rose 50.63% year-over-year to $1.0 million; the TTM value through Jun 2018 reached $1.0 million, up 50.63%, while the annual FY2018 figure was $1.0 million, 50.06% up from the prior year.
  • Payables reached $1.0 million in Q2 2018 per ATHE's latest filing, up from $670405.6 in the prior quarter.
  • Across five years, Payables topped out at $1.0 million in Q2 2018 and bottomed at $670405.6 in Q2 2017.